Hormonal imbalance that irregular menstrual cycles caused by anovulation
This is where remote weight monitoring steps in as a game changer offering a practical and scalable strategy for better ensuring both safety and efficacy in GLP-1 therapy
Preferred injection sites: Abdomen (2 inches away from navel) Front or outer thigh Back of upper arm Site rotation: Alternate injection sites to prevent tissue irritation, scarring, or lipodystrophy
Wegovy is also approved to reduce excess weight and maintain weight reduction long term in certain adults with obesity or overweight and certain children with obesity, for use in addition to a reduced calorie diet and increased physical activity.
Side Effects and Safety Because these medications affect the digestive system, common side effects include: Nausea Diarrhea Vomiting Constipation Yes
GLP-1s can help people with type 2 diabetes, obesity, and overweight